您的位置: 首页 > 农业专利 > 详情页

Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer
专利权人:
Memorial Sloan-Kettering Cancer Center
发明人:
Sawyers, Charles,Ulmert, David,Lewis, Jason,Evans, Michael,Lija, Hans
申请号:
AU2012328679
公开号:
AU2012328679B2
申请日:
2012.10.25
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention provides methods of monitoring and measuring tumor- associated free PSA ("fPSA") with antibody polypeptides as an indication of androgen receptor signaling. In a particular embodiment, the methods may be used to assess the efficacy of anti-androgen and/or general anti-cancer treatments. The present invention also provides various methods and compositions relating to antibodies that are specific for tumor- associated or intratumoral fPSA. For example, the present invention provides compositions, including pharmaceutical compositions, comprising anti-fPSA antibodies, or fragments or characterisitic portions thereof. The present invention further provides various therapeutic and/or diagnostic methods of using anti-fPSA antibodies and/or compositions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充